Concepedia

Ingeborg E A Wijting

IE

Statistics

Publications

6

Citations

283

H-Index

6

Active since

2017

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

University of Groningen

University Medical Center Groningen

University Medical Center Utrecht

Ingeborg E A Wijting is an author at Erasmus MC specializing in antiretroviral therapy, infectious diseases, and antiviral therapy.

ORCID

Publications per year

2017–2019

6

Publications

6

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial

Ingeborg E A Wijting, Casper Rokx, Charles A. Boucher et al. · The Lancet HIV · 2017 · 111 citations · Full text

, , +12

HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy

Ingeborg E A Wijting, Cynthia Lungu, Bart Rijnders et al. · The Journal of Infectious Diseases · 2018 · 79 citations · Full text

, , +17

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

Hanh Thi Pham, Lydia Labrie, Ingeborg E A Wijting et al. · The Journal of Infectious Diseases · 2018 · 40 citations · Full text

, , +17

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

Ingeborg E A Wijting, Ferdinand W.N.M. Wit, Casper Rokx et al. · EClinicalMedicine · 2019 · 30 citations · Full text

, , +17

Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy

Ingeborg E A Wijting, Casper Rokx, Maria Carola Zillikens et al. · International Journal of STD & AIDS · 2019 · 12 citations · Full text

, , +17

1–5 of 6